May 17, 2017
Croatian Belupo opens new €71M worth factory
Belupo, Croatia-based pharmaceutical company and a part of the Podravka Group has opened new factory worth €71 million.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
May 17, 2017
Hikma launches Ethacrynic Acid Tablets in the US market
Hikma Pharmaceuticals’s US subsidiary West-Ward Pharmaceuticals has launched Ethacrynic Acid Tablets USP in 25mg strength, the generic equivalent to Edecrin (ethacrynic acid) for the treatment of edema when an agent with greater diuretic potential than those commonly employed is required.
May 17, 2017
Sobi’s hereditary tyrosinemia drug approved in Saudi Arabia
The Saudi Food and Drug Administration (SFDA) has approved Swedish Orphan Biovitrum’s (Sobi) Orfadin (nitisinone) capsules in all strengths (2 mg, 5 mg, 10 mg and 20 mg) for the treatment of hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.
May 17, 2017
Bayer wins FDA’s Priority Review for its follicular lymphoma drug
The U.S. Food and Drug Administration (FDA) has granted Priority Review designation for the New Drug Application (NDA) for Bayer’s copanlisib for the treatment of relapsed or refractory follicular lymphoma (FL) patients who have received at least two prior therapies.
May 17, 2017
Nicox welcomes new Board member
Nicox, the international ophthalmic R&D company, appointed Lauren P. Silvernail to the its Board of Directors, for a period of four years.
May 16, 2017
New York county sues Purdue, J&J over opioid marketing
A county in New York state has sued Purdue Pharma LP, Johnson & Johnson <JNJ.N> and other drugmakers, accusing them of engaging in fraudulent marketing that played down the risks of prescription opioid painkillers, leading to a drug epidemic.
May 16, 2017
Advent, Shanghai Pharma have not approached Stada – sources
German drug company Stada Arzneimittel AG has not been approached by Advent International or Shanghai Pharmaceuticals Holding with a counter offer, two sources close to the matter told Reuters on Monday.
May 15, 2017
US District Court upholds Horizon Pharma’s patent
The United States District Court for the District of New Jersey upheld the validity of Horizon Pharma’s patent covering Pennsaid (diclofenac sodium topical solution) 2% w/w, which Actavis Laboratories UT, Inc.(Actavis) has admitted that its proposed generic diclofenac sodium topical solution product would infringe.
May 15, 2017
Mereo BioPharma wraps up patients testing for its rare pulmonary disease drug
Mereo BioPharma Group, a clinical stage, biopharmaceutical company focused on rare and specialty diseases, has completed patient enrolment in the AETHER, multi-centre, double-blind, placebo-controlled Phase 2 dose-ranging study of acumapimod (BCT-197), for the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
May 12, 2017
WHO wants transparency, market revamp for fairer drug pricing
The world needs greater transparency on the pricing of medicines, and an overhaul of some approaches, in order to increase access to life-saving drugs, global health experts said on Thursday.